All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 195 of 206 pages ‹ First < 193 194 195 196 197 > Last ›
HSL3308
Re: the promotion of vitamins A & E
1985 Sep 01;
HSL8352
Concerning the case of: United States v. American Pharmaceutical Association and Michigan State Pharmaceutical Association, Civil No. G75-558 CA5, W.D.
Journal Michigan Pharmacist 1985 Sep;23:14-15
HSL8364
Gross A.
TV or not TV? it's more than one question
Pharmaceutical Executive 1985 Sep;5:50, 52, 54
HSL8372
Schlegel expresses pharmacist concerns over differential pricing, inflation
American Pharmacy 1985 Sep;6-7
HSL9657
Wasserman MD.
Worldwide maintenance of drug product quality
Drug Cosmet Ind 1985 Sep;137:35, 38, 40
HSL9665
Dickinson J.
United States diversion schemes threaten integrity of US prescription drugs
Pharmaceutical Journal 1985 Aug 3;235:144-145
HSL3307
Re: the promotion of tetracycline
1985 Aug 01;
HSL3276
Jefferis JE.
The pharmaceutical industry and academic medicine: opportunities for physician collaboration.
Circulation 1985 Aug;72:(2):
HSL3277
Kaplan NM.
Educating physicians in the use of pharmaceuticals.
Circulation 1985 Aug;72:(2):
HSL8363
Goldstein GS.
Corporate communication strategies-prescription from a medical director
Pharmaceutical Executive 1985 Aug;5:54-56
HSL3288
Murphy PA.
One drug company's sales techniques.
N Engl J Med 1985 Jul 25;313:(4):270
HSL8371
Robinson B.
Pharmacists see need for controls on Rx sampling
Drug Topics 1985 Jul 15;129:12-14
HSL3286
Miller K, Gouveia WA, Barza M, Bower K, Curtis L, Decker EL, Dorkin H, Estes M, Mackey W, Marchbein D, et al.
Undesirable marketing practices in the pharmaceutical industry.
N Engl J Med 1985 Jul 4;313:(1):54
HSL8360
Kaplan A, Becker R.
FDA and the single-sponsor journal
Pharmaceutical Executive 1985 Jul;5:48-49
HSL8370
Danielson DA.
Influencing the physician-drug industry strategies
Generics 1985 Jul;1:32-34, 37-40, 42-43
HSL9644
O'Sullivan PJ.
Generic medicines: a prescription for decline
Irish Pharmaceutical Union Review 1985 Jul-Aug;10:241-242, 244, 246-247
HSL9664
ABPI code of practice committee: seven complaints upheld (three of them against Lederle)
Pharmaceutical Journal 1985 Jun 22;234:782-783
HSL3305
Gould D.
Funds that can foster suspicion
New Scientist 1985 Jun 13;106:30
HSL20474
Mansfield PR
An eye on pharmaceutical marketing
Australian Doctor 1985 Jun 6
HSL3302
Re: the promotion of pizotifen
1985 Jun 01;
HSL3306
Re: the promotion of ampicillin (Binotal) in Indonesia
1985 Jun 01;
HSL3303
Mansfield PR.
Protecting the innocent from harm: the Medical Lobby for Appropriate Marketing (MLAM)
New Doctor 1985 Jun;(36):22-24
HSL9666
Labson D.
Measuring the effectiveness of nonjournal media
Pharmaceutica Executive 1985 Jun;5:48-51
HSL9671
Williams PC.
Sound impressions
Pharmaceutical Executive 1985 Jun;5:58-59
HSL20494
Smith D
When misleading ads can kill
The National Times 1985 May 23
HSL9652
Crossen DK.
Providing just what the doctor ordered
Pharmaceutical Executive 1985 May;5:84-85
HSL9670
Kissel S, Flaum S.
There's a bit of consumer in every M.D.
Pharmaceutical Executive 1985 May;5:54, 56-57
HSL3301
Sivarajan M.
Tarnishing the medical profession's image.
N Engl J Med 1985 Apr 25;312:(17):1132
HSL3300
MLAM letter update
MLAM Newsletter 1985 Apr 01
HSL3327
Bowman MA.
The impact of the expanding supply of physicians on continuing medical education.
Mobius 1985 Apr;5:(2):28-31
HSL8377
Pharmaceuticals have flat year-with exceptions
American Druggist 1985 Apr;191:154
HSL8380
Limited list: PM attacks ABPI advertisement
Pharmaceutical Journal 1985 Mar 9;234: 297
HSL20473
Miller C
Drug ads in Third World need scrutiny
Australian Doctor 1985 Mar 628
HSL3298
MLAM in the medical media
MLAM Newsletter 1985 Mar 01
HSL3299
Kunin CM.
The responsibility of the infectious disease community for the optimal use of antimicrobial agents.
J Infect Dis 1985 Mar;151:(3):388-98
HSL8356
Wicker WV, Dingell JD.
Prescription drug advertising to consumers
Pharmaceutical Executive 1985 Mar;5:61-62
HSL8365
Millstein LG.
What price drug advertising?
Pharmaceutical Executive 1985 Mar;5:56, 59
HSL8366
Shuler J.
Eliminating the ambiguities
Pharmaceutical Executive 1985 Mar;5:13
HSL3282
Loshak D.
Anti-inflammatory drugs under fire.
Lancet 1985 Feb 16;1:(8425):410
HSL3292
Smith R.
Doctors and the drug industry in Sweden.
Br Med J (Clin Res Ed) 1985 Feb 9;290:(6466):448-50
HSL8390
Limited list: facts and fallacies rebutted
Pharmaceutical Journal 1985 Feb 9;234:164-165
HSL8385
Limited list prescribing: Society's comments on Minister's provisional list
Pharmaceutical Journal 1985 Feb 2;234:146-149
HSL3270
Bland JM, Jones DR, Bennett S, Cook DG, Haines AP, MacFarlane AJ.
Is the clinical trial evidence about new drugs statistically adequate?
Br J Clin Pharmacol 1985 Feb;19:(2):155-60
HSL8355
Rose M, Merk P.
Forecasting-when history does not repeat itself
Pharmaceutical Executive 1985 Feb;5:36-38, 72
HSL8361
Boggs D, Clarke DG.
Predicting product potential
Pharmaceutical Executive 1985 Feb;5:31-32, 35
HSL8362
Schwartz H.
Blocking the industry's fast lane
Pharmaceutical Executive 1985 Feb;5:13-14
HSL8378
Cooper P.
Limiting the prescriber
Irish Pharmacy Journal 1985 Feb;63:59-60
HSL3297
Re: the promotion of Lomotil
1985 Jan 01;
HSL8382
Congressional report advises against prescription drug ads to consumers
American Pharmacy 1985 Jan;18
HSL1324
Goleman D.
Vital lies, simple truths: The psychology of self-deception.
London: Bloomsbury 1985
http://www.amazon.com/exec/obidos/tg/detail/-/0684831074/103-6888207-0054229?v=glance
HSL2100
Woolgar S, Pawluch D.
Ontological gerrymandering: The anatomy of social problems explanations.
Social Problems 1985;32:214-27
http://pos.sagepub.com/cgi/content/refs/35/2/175
HSL2144
Ferry ME, Lamy PP, Becker LA.
Physicians' knowledge of prescribing for the elderly. A study of primary care physicians in Pennsylvania.
J Am Geriatr Soc 1985;33:616-21
HSL3266
The battle over physicians’ samples
Lancet 1985;2:1001
HSL3267
WHO meeting agrees on rational drugs strategy
Lancet 1985;2:1350-1351
HSL3268
Bateman DN.
Ethics of drug marketing
Lancet 1985;1:166
HSL3269
Benseman J.
The great paper waste: the use of unsolicited medical literature by general practitioners
New Zealand Family Physician 1985;12:96-98
HSL3271
Collier J.
Ethics of drug marketing
Lancet 1985;1:166-167
HSL3272
Curran V, Golombok S.
Bottling it up
1985;
HSL3273
Dasco CC.
A physician/medical industrial ethos
American Journal of Medicine 1985;79:675
HSL3274
Eastman HC.
Report of the commission of inquiry on the pharmaceutical industry
1985;
HSL3278
Krupka LR, Vener AM.
Prescription drug advertising: trends and implications.
Soc Sci Med 1985;20:(3):191-7
HSL3279
Lefever R.
Market research in sheep’s clothing
Lancet 1985;1:760
HSL3280
Lexchin J.
Diuretic-induced hypokalemia in hypertension
Canadian Medical Association Journal 1985;133:183
HSL3283
Mackowiak JI, Gagnon JP.
Effects of promotion on pharmaceutical demand.
Soc Sci Med 1985;20:(11):1191-7
HSL3284
Magor G.
Who sends junk mail?
Canadian Family Physician 1985;31:911
HSL3285
Masson A, Rubin PH.
Matching prescription drugs and consumers: The benefits of direct advertising.
New England Journal of Medicine 1985;313:513-515
HSL3287
Mintz M.
At any cost: corporate greed, women, and the Dalkon Shield
1985;
HSL3290
Osiobe SA.
Use of information resources by health professionals: a review of the literature.
Soc Sci Med 1985;21:(9):965-73
HSL3291
Putnam RW, Fox RD, Mazmanian PE.
Report to Pharmaceutical Manufacturers Association of Canada: an analysis of drug prescribing changes by physicians
1985;
HSL3293
Van DER.
Marketing myths: selling drugs in the Third World
Medicine in Society 1985;2:(2):41-45
HSL3295
Woods D.
Annual report to the readers
Canadian Medical Association Journal 1985;132:7
HSL3296
Woods D, Radford T.
Annual meeting 1985
Canadian Medical Association Journal 1985;133:591-594, 597
HSL8354
Haverkost LF.
How industry assesses and picks suitable candidates for switch
Drug Information Journal 1985;19:(2):133-138
HSL8359
Hutt PB.
Drugs for self-medication in the future: their source and the social, political, and regulatory climate
Drug Information Journal 1985;19:(2):195-199
HSL8368
Guerard C.
Impact of advertising and its regulation: Federal Trade Commission perspective
Drug Information Journal 1985;19:(2):163-172
HSL13295
Monroe KB, Krishnan R.
Effect of Price on Subjective Product Evaluations
Jacoby J, Olson JG. Perceived Quality New York: Lexington Books 1985
http://www.amazon.com/gp/offer-listing/0669082724/ref=sr_1_olp_9?ie=UTF8&s=books&qid=1206440499&sr=1-9
HSL16713
Wolfe S, Greenberg A
Letter to the Editor on Bjork?Shiley Convexo?Concave heart valve
NEJM 1985;312:314‑315
HSL20337
Elstein AS, Dawson-Saunders B, Belzer LJ
Instruction in Medical Decision Making
Med Decis Making 1985;5:(2):228-233
http://mdm.sagepub.com/content/5/2/229.extract
HSL20525
Inman WHW
Let's get our act together
Side Effects of Drugs Annual 1985;9: xv–xxiii
http://www.sciencedirect.com/science/article/pii/S0378608085800040
HSL20539
Dukes MNG
Pharmaceuticals: Take Another Look
Pharmaceut. Med. 1985;1:117-127
HSL11490
Drug Maker Pleads Guilty Over Lethal Side Effects
Associated Press 1984 Dec 14
http://query.nytimes.com/gst/fullpage.html?sec=health&res=9501E2DF1338F937A25751C1A962948260
HSL8384
White JP.
Prescriptions: growth, gyrations, generics
Drug Topics 1984 Dec 10;128:46, 48-49, 52
HSL8393
Limited list prescribing: ABPI begins campaign against stupid and dangerous proposal
Pharmaceutical Journal 1984 Dec 8;233:712-713
HSL3188
Collier J.
Unconvincing reassurance from the ABPI.
Lancet 1984 Dec 1;2:(8414):1280
HSL3253
Re: the promotion of Binotal
1984 Dec 01;
HSL8379
Schwartz H.
Are doctors' offices troubled waters for the industry?
Pharmaceutical Executive 1984 Dec;4:14, 16
HSL20478
Fowler J
'War' on the drug firms who cheat
Daily News 1984 Nov 2310
HSL20479
Fighting killer drugs
The West Australian 1984 Nov 2131
HSL3186
Collier J.
Misleading advertisements: sanctions and corrections.
Lancet 1984 Nov 10;2:(8411):1097-8
HSL3197
Statement on ethical conduct in research by the Infectious Diseases Society of America.
J Infect Dis. 1984 Nov 01;150:(5):792-3
HSL8394
Pharmaceutical R&D must be encouraged and supported, CMA tells the Eastman Commission
Canadian Medical Association Journal 1984 Nov 1;131:1095-1097
HSL8395
Give us more protection, innovative drug manufacturers tell Eastman Commission
Canadian Medical Association Journal 1984 Nov 1;131:1097-1098
HSL3225
Yudkin JS.
Use and misuse of drugs in the Third World.
Dan Med Bull 1984 Nov;31:
HSL8375
Schwartz H.
There's no profit in misunderstanding
Pharmaceutical Executive 1984 Nov;4:14, 16-17
HSL8376
Shuler J.
Indirect Rx advertising to consumers
Pharmaceutical Executive 1984 Nov;4:10
HSL8381
Schaaf D.
Hospital pharmacy and industry-rivals or partners
Krankenhauspharmazie 1984 Nov;5:347-351
HSL8397
Buchanan C.
Requiring rational promotions as part of a bid request
American Journal of Hospital Pharmacy 1984 Nov;41:2320, 2324
HSL20224
Andrews G
On the promotion of non-drug treatments
BMJ 1984 Oct 13;289:
http://www.bmj.com/content/289/6450/994
HSL20483
MLAM
Round the World: From our Correspondents: Australia: MLAM
Lancet 1984 Oct 13;861
HSL3212
Rawlins MD.
Doctors and the drug makers.
Lancet 1984 Oct 6;2:(8406):814
Page 195 of 206 pages ‹ First < 193 194 195 196 197 > Last ›
